AR069892A1 - Furina recombinante libre de proteinas sustancialmente animal y metodos para producirla. composicion. - Google Patents
Furina recombinante libre de proteinas sustancialmente animal y metodos para producirla. composicion.Info
- Publication number
- AR069892A1 AR069892A1 ARP080105645A AR069892A1 AR 069892 A1 AR069892 A1 AR 069892A1 AR P080105645 A ARP080105645 A AR P080105645A AR 069892 A1 AR069892 A1 AR 069892A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- free
- methods
- animal proteins
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Furina recombinante (rFurina) y métodos para producir la rFurina. Más específicamente, rFurina libre de proteínas sustancialmente animal y métodos para producir la rFurina libre de proteínas sustancialmente animales. Reivindicacion 1: Una composicion caracterizada porque comprende furina recombinante libre de proteínas sustancialmente animal. Reivindicacion 2: La composicion de la reivindicacion 1 caracterizada porque comprende furina recombinante a una actividad de por lo menos alrededor de 10000 U de furina/ml y CHO proteínas de células huésped a una concentracion menos de alrededor de 11 mg proteína/ml. Reivindicacion 14: Un método de uso de la composicion de la reivindicacion 1 caracterizado porque comprende el paso de contactar a pro-proteína con la composicion en condiciones para disociar un pro-péptido de la pro-proteína para formar una proteína madura. Reivindicacion 15: El método de la reivindicacion 14 caracterizado porque la proteína madura es Factor de von Willebrand. Reivindicacion 16: El método de la reivindicacion 14 caracterizado porque la proteína madura es Factor VIII.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1815207P | 2007-12-31 | 2007-12-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR069892A1 true AR069892A1 (es) | 2010-02-24 |
Family
ID=40524590
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080105645 AR069892A1 (es) | 2007-12-31 | 2008-12-19 | Furina recombinante libre de proteinas sustancialmente animal y metodos para producirla. composicion. |
| ARP180103625A AR113492A2 (es) | 2007-12-31 | 2018-12-12 | Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180103625A AR113492A2 (es) | 2007-12-31 | 2018-12-12 | Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20090181423A1 (es) |
| EP (2) | EP2240578B1 (es) |
| JP (2) | JP5806465B2 (es) |
| KR (1) | KR101618144B1 (es) |
| CN (2) | CN110066782B (es) |
| AR (2) | AR069892A1 (es) |
| AU (1) | AU2008346817B2 (es) |
| BR (1) | BRPI0821467B8 (es) |
| CA (1) | CA2710260C (es) |
| DK (1) | DK2240578T3 (es) |
| ES (2) | ES2735173T3 (es) |
| HU (1) | HUE043863T2 (es) |
| MX (1) | MX2010007344A (es) |
| NZ (1) | NZ586411A (es) |
| PL (2) | PL2240578T3 (es) |
| PT (1) | PT2240578T (es) |
| SG (2) | SG10201805749QA (es) |
| WO (1) | WO2009088713A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2157177E (pt) * | 2007-05-22 | 2013-04-18 | Baxter Int | Processo de purificação preparativo para a furina humana |
| SG10201805749QA (en) | 2007-12-31 | 2018-08-30 | Baxalta Inc | Substantially animal protein-free recombinant furin and methods for producing same |
| US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
| PL3064508T5 (pl) | 2010-07-08 | 2024-04-08 | Takeda Pharmaceutical Company Limited | Sposób wytwarzania rekombinowanego vwf o dużej masie cząsteczkowej w hodowli komórkowej |
| WO2012122611A1 (en) * | 2011-03-11 | 2012-09-20 | Universidade De São Paulo - Usp | Method for the production of recombinant human factor viii |
| SG195261A1 (en) | 2011-06-02 | 2013-12-30 | Baxter Int | Formulations of recombinant furin |
| AR102048A1 (es) * | 2014-08-12 | 2017-02-01 | Baxalta Inc | Producción del factor x completamente procesado y funcional en un sistema de expresión de mamífero de secreción de furina |
| MX2017008338A (es) * | 2014-12-22 | 2017-10-19 | Genzyme Corp | Metodos de cultivo de una celula de mamifero. |
| CA3068121A1 (en) | 2017-06-23 | 2018-12-27 | Baxalta Incorporated | Purification of factor viii subspecies |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1815207A (en) | 1929-01-18 | 1931-07-21 | John H Moffat | Vehicle parking and locking device |
| NL9000917A (nl) | 1989-10-25 | 1991-05-16 | Holland Biotechnology | Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten. |
| EP0785273A1 (en) * | 1990-11-26 | 1997-07-23 | Genetics Institute, Inc. | Paired basic amino acid converting enzyme and DNA sequence encoding it |
| US5604201A (en) * | 1993-01-08 | 1997-02-18 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization | Methods and reagents for inhibiting furin endoprotease |
| AT404838B (de) | 1995-11-24 | 1999-03-25 | Immuno Ag | Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen |
| ATE399855T1 (de) | 1996-10-10 | 2008-07-15 | Invitrogen Corp | Tierzellkulturmedium mit pflanzlichen nährstoffen |
| AT407750B (de) | 1999-02-19 | 2001-05-25 | Immuno Ag | Verfahren zur herstellung einer vwf-präparation |
| US6596526B1 (en) * | 2000-06-09 | 2003-07-22 | Baxter Aktiengesellschaft | Furin polypeptides with improved characteristics |
| SE0103084D0 (sv) * | 2001-09-14 | 2001-09-14 | Amersham Pharm Biotech Ab | Generation of ion exchange media |
| US20030091976A1 (en) | 2001-11-14 | 2003-05-15 | Ciphergen Biosystems, Inc. | Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry |
| DK1520008T3 (da) * | 2002-07-09 | 2012-10-15 | Baxter Int | Medium frit for dyreprotein til dyrkning af celler |
| US7750129B2 (en) * | 2004-02-27 | 2010-07-06 | Ge Healthcare Bio-Sciences Ab | Process for the purification of antibodies |
| RU2486236C2 (ru) * | 2006-01-04 | 2013-06-27 | Бакстер Интернэшнл Инк. | Способ экспрессии белка |
| PT2157177E (pt) * | 2007-05-22 | 2013-04-18 | Baxter Int | Processo de purificação preparativo para a furina humana |
| SG10201805749QA (en) | 2007-12-31 | 2018-08-30 | Baxalta Inc | Substantially animal protein-free recombinant furin and methods for producing same |
| WO2013070520A2 (en) | 2011-11-03 | 2013-05-16 | Barson Composites Corporation | Corrosion-resistant diffusion coatings |
-
2008
- 2008-12-19 SG SG10201805749QA patent/SG10201805749QA/en unknown
- 2008-12-19 PT PT08869658T patent/PT2240578T/pt unknown
- 2008-12-19 BR BRPI0821467A patent/BRPI0821467B8/pt active IP Right Grant
- 2008-12-19 PL PL08869658T patent/PL2240578T3/pl unknown
- 2008-12-19 CN CN201811405688.6A patent/CN110066782B/zh active Active
- 2008-12-19 CN CN2008801240838A patent/CN101910401A/zh active Pending
- 2008-12-19 SG SG2013051693A patent/SG192471A1/en unknown
- 2008-12-19 WO PCT/US2008/087732 patent/WO2009088713A1/en active Application Filing
- 2008-12-19 KR KR1020107017148A patent/KR101618144B1/ko active IP Right Grant
- 2008-12-19 JP JP2010540818A patent/JP5806465B2/ja active Active
- 2008-12-19 PL PL19163119T patent/PL3521422T3/pl unknown
- 2008-12-19 MX MX2010007344A patent/MX2010007344A/es active IP Right Grant
- 2008-12-19 US US12/339,597 patent/US20090181423A1/en not_active Abandoned
- 2008-12-19 HU HUE08869658A patent/HUE043863T2/hu unknown
- 2008-12-19 DK DK08869658.8T patent/DK2240578T3/da active
- 2008-12-19 AU AU2008346817A patent/AU2008346817B2/en active Active
- 2008-12-19 NZ NZ586411A patent/NZ586411A/en unknown
- 2008-12-19 CA CA2710260A patent/CA2710260C/en active Active
- 2008-12-19 AR ARP080105645 patent/AR069892A1/es active IP Right Grant
- 2008-12-19 EP EP08869658.8A patent/EP2240578B1/en active Active
- 2008-12-19 ES ES08869658T patent/ES2735173T3/es active Active
- 2008-12-19 ES ES19163119T patent/ES2897561T3/es active Active
- 2008-12-19 EP EP19163119.1A patent/EP3521422B1/en active Active
-
2010
- 2010-12-03 US US12/960,093 patent/US9127264B2/en active Active
-
2015
- 2015-06-03 JP JP2015112866A patent/JP2015154790A/ja not_active Withdrawn
-
2018
- 2018-12-12 AR ARP180103625A patent/AR113492A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR069892A1 (es) | Furina recombinante libre de proteinas sustancialmente animal y metodos para producirla. composicion. | |
| Haralson et al. | Chinese hamster lung cells synthesize and confine to the cellular domain a collagen composed solely of B chains. | |
| NO2017028I1 (no) | eftrenonacog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet. | |
| ATE272393T1 (de) | Rekonstruktion gereinigter membranproteine in vorgefertigten liposomen | |
| NZ591292A (en) | Improved cell composition and methods of making the same | |
| NZ595495A (en) | Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them | |
| MXPA03010433A (es) | Metodos para produccion recombinante de peptidos antifusogenicos. | |
| DK1755634T3 (da) | Oligopeptider til formindskelse af forhöjet blodurinstofkoncentration | |
| DK1210411T3 (da) | Sammensætninger og fremgangsmåder til forbedret celledyrkning | |
| CO6231052A2 (es) | Polipeptidos de factor vii modificados y usos de los mismos | |
| AR035786A2 (es) | Variantes de factores de coagulacion dependientes de vitamina k y composiciones que los contienen | |
| ATE404583T1 (de) | Funktionelle antagonisten von hedgehog-aktivität | |
| ATE272109T1 (de) | Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden | |
| AR084530A2 (es) | Un metodo para facilitar la produccion del virus del sindrome reproductor y respiratorio porcino (prrsv) a partir de un cultivo de celulas de vertebrados | |
| DE69939330D1 (de) | Wachstumsfaktor-homologe zvegf-3 | |
| ATE257514T1 (de) | Verfahren zur gewinnung von aktivem beta-ngf | |
| Bab et al. | Isolation of mitogenically active C‐terminal truncated pentapeptide of osteogenic growth peptide from human plasma and culture medium of murine osteoblastic cells | |
| ATE290089T1 (de) | Methode zur verstärkung der biologischen aktivität von liganden | |
| AR012499A1 (es) | Una secuencia quimerica de acido nucleico que codifica una proteina de fusion, un vector de expresion que comprende dicha secuencia quimerica, una celula huesped transformada que contiene dicho vector, la proteina de fusion obtenida y un metodo in vitro para la preparacion de un polipeptido recombin | |
| Jankowski et al. | Defining ‘full‐length’recombinant factor VIII: a comparative structural analysis | |
| DE60235985D1 (de) | Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk) | |
| ES2192199T3 (es) | Ligandos de la familia eph biologicamente activos. | |
| TR200200048T2 (tr) | Otoproteolitik klevaj vasıtasıyla proteinlerin üretimi. | |
| ATE233321T1 (de) | Verbesserungen in der herstellung von proteinen in wirtszellen | |
| ATE399794T1 (de) | Modifizierter granulozyten stimulierender factor (g-csf) mit verringerter immunogenität |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |